Beijing Kangbeide

Beijing Kangbeide is a specialized pharmaceutical company based in China that focuses on the development and commercialization of transdermal drug delivery systems (TDDS). The company leverages its proprietary technology platform to create high-barrier complex formulations, primarily in the form of transdermal patches for pain management and central nervous system disorders. Their commercial portfolio includes fentanyl and rivastigmine patches, which offer improved patient compliance and steady-state drug release compared to oral alternatives. Beijing Kangbeide maintains a robust pipeline with candidates targeting Parkinson's disease and chronic pain, utilizing advanced adhesive and controlled-release technologies. The firm operates integrated R&D and GMP-certified manufacturing facilities to support its specialized product line. As a leader in the Chinese TDDS market, the company continues to innovate in the field of non-invasive, long-acting medication delivery.